Is MRTFA p.Pro406Ala (c.1216C>G) pathogenic?

MRTFA p.Pro406Ala (c.1216C>G) is classified Likely benign in MRTFA (ClinVar, Single submitter, 1 submitter; last evaluated 2026-01-12). AlphaMissense: likely benign (0.0524); Rare (popmax 0.245%, amr).

How common is MRTFA p.Pro406Ala (c.1216C>G) in the general population?

MRTFA p.Pro406Ala (c.1216C>G) is rare (popmax 0.245%, amr) (gnomAD).

What do computational predictors say about MRTFA p.Pro406Ala (c.1216C>G)?

AlphaMissense predicts likely benign (score 0.0524) — an in-silico prediction, not a clinical call.

MRTFA p.Pro406Ala

c.1216C>G · rs750387386 · VCV1683105

Likely benign Single submitter

Classification

Likely benign

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.0524 · ACMG-weighted

gnomAD v4.1

Rare

rare (popmax 0.245%, amr)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.0524	likely benign
REVEL	0.031	moderately benign-leaning
SaProt	LLR -5.75	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 0.92	GERP -1.2, phastCons 0.42
Regional constraint	o/e 1.06	unconstrained · MANE · 13 kb · p 0.043 · regional, not allelic
Overall
CADD	4.256	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM P306A vs ClinVar P406A) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.245% Admixed American · 147/60,008 alleles

Filtering AF 0.213% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.2%

Overall 0.00923% 149/1,613,510 alleles · rare exomes 139/1,461,244 · genomes 10/152,266 · joint denominator

Ancestry group	Frequency	1 in
Admixed Americangrpmax	0.245%	408
Remaining individualsnot grpmax-eligible	0.0016%	62,470
European (non-Finnish)	8.47e-05%	1,180,026

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: MRTFA
Protein: p.Pro406Ala
Coding: c.1216C>G
MANE Select: NM_020831
dbSNP: rs750387386
Type: single nucleotide variant
Location: chr22:40420542 (GRCh38)
Gene constraint: LOEUF 0.389 · pLI 1.00 (gnomAD)
Structure: AlphaFold pLDDT 56.59 · 2 PDB
Residue 306 UniProt numbering: the 'disordered' region

Full MRTFA gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

MRTFA p.Pro406His Conflicting classifications of pathogenicity ★ ⚠ same residue
MRTFA p.Pro406Leu Uncertain significance ★ ⚠ same residue
MRTFA p.Pro406Thr Uncertain significance ★ ⚠ same residue
MRTFA p.Ala352Thr Uncertain significance ★★ ⚠ same type
MRTFA p.Ala360Thr Uncertain significance ★★ ⚠ same type
MRTFA p.Ala429Ser Uncertain significance ★★ ⚠ same type
MRTFA p.Ala479Gly Uncertain significance ★★ ⚠ same type
MRTFA p.Ala479Val Uncertain significance ★★ ⚠ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mrtfa-p-pro406ala (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown